# Tumor-Lymph Node Mapping

> **NCT07054944** · — · RECRUITING · sponsor: **University of Rochester** · enrollment: 10 (estimated)

## Conditions studied

- Pediatric Solid Tumors
- Rhabdomyosarcoma
- Sarcoma
- Germ Cell Tumor

## Interventions

- **DIAGNOSTIC_TEST:** ICG (Indocyanine Green)

## Key facts

- **NCT ID:** NCT07054944
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-13
- **Primary completion:** 2028-07-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07054944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07054944, "Tumor-Lymph Node Mapping". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07054944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*